We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Global Anesthesia and Respiratory Devices Market to Reach USD 38 Billion by 2023

By HospiMedica International staff writers
Posted on 01 Mar 2019
The global anesthesia and respiratory devices market is expected to grow at a CAGR of 7.2% from USD 25.21 billion in 2017 to USD 38.29 billion by 2023, driven by the rising prevalence of respiratory diseases, increase in the number of surgical procedures, surge in pollution levels, higher tobacco consumption, rapid urbanization and supportive government policies. More...
However, risks related to therapeutic and diagnostic devices for neonates and the low adoption rate of new technologies will restrain the market growth. Nevertheless, an increase in the demand for therapeutic devices for homecare settings and a surge in healthcare expenditures will create new opportunities in the global anesthesia and respiratory devices market.

These are the latest findings of Allied Market Research (Portland, OR, USA), a full-service market research and business consulting firm.

Based on product type, the respiratory devices segment is the most lucrative and held nearly three-fifths of the total market share in 2017, owing to the high prevalence of respiratory diseases and availability of advanced respiratory devices. The segment is expected to maintain its dominance and grow at the fastest CAGR of 7.3% during the forecast period, driven by a significant rise in pollution across the world, lack of awareness about the utilization of masks for protection against aerosols and other particulate matter, and rising prevalence of respiratory diseases such as asthma, respiratory infections, and tuberculosis. Based on end user, the hospitals segment dominates the anesthesia and respiratory devices market, although the clinics segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America held two-fifths of the share in the global anesthesia and respiratory devices market in 2017. The North American market is expected to maintain its dominant share throughout the forecast period due to technological advancements in medications & surgical equipment and the rising adoption of modern anesthetics in the region. However, the market in Asia-Pacific is projected to register the highest CAGR of 8.1% during the forecast period, driven by a surge in respiratory disorders such as COPD, asthma, and lung cancer, increase in the geriatric population and growing inclination toward homecare monitoring in the region.

Related Links:
Allied Market Research


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.